Dov A. Goldstein MD - 01 Feb 2026 Form 4 Insider Report for BioAge Labs, Inc. (BIOA)

Role: Chief Financial Officer
Signature: /s/ Dov A. Goldstein
Issuer symbol: BIOA
Transactions as of: 01 Feb 2026
Net transactions value: +$15,510
Form type: 4
Filing time: 03 Feb 2026, 16:23:00 UTC
Previous filing: 21 Jan 2026
Next filing: 19 Feb 2026
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
GOLDSTEIN DOV A MD	Chief Financial Officer	C/O BIOAGE LABS, INC., 5885 HOLLIS STREET, SUITE 370, EMERYVILLE	/s/ Dov A. Goldstein	03 Feb 2026	0001120478

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	BIOA	Common Stock	Options Exercise	$15,510	+3,541	+14%	$4.38	29,491	01 Feb 2026	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	BIOA	Stock Option (Right to Buy)	Options Exercise	$0	-3,541	-2.1%	$0.000000	162,917	01 Feb 2026	Common Stock	3,541	$4.38	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The option vested or vests as to 1/48th of the total award monthly, with the first tranche vested on February 1, 2025, and each subsequent tranche vesting on the monthly anniversary thereof, subject to the reporting person's continued service to the Issuer on each vesting date.